-
-
-
-
-
-
News
-
-
Contact UsThe company focuses on the research, development, production, and sales of chemical raw materials and their formulations. All products have passed national GMP certification, and core products have successively passed official pharmaceutical regulatory certifications from multiple countries, including the EU EDQM, US FDA, Japanese PMDA, and South Korean MFDS. Following its successful listing on the Shenzhen Stock Exchange's ChiNext board on April 4, 2023, Keyuan Pharmaceutical has entered a phase of rapid development driven by both digital intelligence and capital, with its business spanning dozens of countries and regions worldwide.
Keyuan Group is conducting AI application training for all employees, unlocking new momentum for corporate development!
Publish Time:
2026-03-10
To keep pace with the rapid advancement of AI technology, foster deep integration between AI and pharmaceutical operations, and comprehensively enhance the AI application capabilities of all employees, Keyuan Group organized a series of AI application training sessions for its entire workforce on March 10. Employees of Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical participated in this training, jointly unlocking new skills in AI tool applications and strengthening the talent foundation for the company’s digital and intelligent transformation.
To keep pace with the rapid advancement of AI technology, foster deep integration between AI and pharmaceutical operations, and comprehensively enhance the AI application capabilities of all employees, Keyuan Group organized a series of AI application training sessions for its entire workforce on March 10. Employees of Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical participated in this training, jointly unlocking new skills in AI tool applications and strengthening the talent foundation for the company’s digital and intelligent transformation.
This training program is anchored in the Group’s digital and intelligent transformation strategy, aligning with the unique characteristics of the pharmaceutical industry and the company’s actual business needs. It provides on-site insights into the global AI landscape and cutting-edge trends in AI applications within the pharmaceutical sector, while sharing real-world implementation cases of AI in core business areas such as drug R&D, intelligent manufacturing, quality control, and supply chain management. The trainers offer systematic instruction on AI prompt engineering and hands-on use of mainstream AI tools, covering diverse application scenarios including copywriting, creative design, video production, and office productivity enhancement. Through a combination of theoretical lectures, case studies, live demonstrations, and practical exercises, the program guides employees in developing an AI mindset and mastering methods for integrating AI tools into their daily work. At the same time, it clearly outlines the ethical, safety, and compliance requirements for AI applications, helping employees leverage AI technology in a standardized and highly efficient manner.
At a time when digital and intelligent transformation has become a core trend in corporate development, this company-wide AI application training is not only an inevitable requirement for Keyuan Group to respond to industry changes and enhance its core competitiveness, but also a crucial lever for empowering employee growth and driving the seamless integration of AI technology across the entire business value chain. Through this training, all employees have systematically learned the fundamentals of AI and practical skills, further broadening their perspectives on AI applications and achieving a shift from “understanding AI” to “being able to use AI.” This has effectively cultivated digital and intelligent literacy among all staff, laying a solid foundation for the deep integration of AI technology into every stage of drug R&D, production manufacturing, marketing, and corporate management in the future.
Technology empowers the future, and digital intelligence leads development. This company-wide AI application training program marks an important step for Keyuan Group in embracing the AI era and accelerating its digital and intelligent transformation. Moving forward, Keyuan Group will continue to focus on the cutting edge of AI technology development, constantly refining its employee digital and intelligent training system, promoting the deep integration and innovative applications of AI technology with its core pharmaceutical business, and consistently cultivating versatile talents who possess both strong business expertise and robust AI application capabilities. By doing so, Keyuan Group aims to make AI technology a powerful driving force behind the company’s innovative development, enabling it to achieve steady, long-term growth while seizing the initiative and gaining a competitive edge in the digital and intelligent transformation of the pharmaceutical industry.
Latest News
Address: No. 26, Keyuan Street, Shanghe County, Jinan City, Shandong Province
Free Service Hotline